Breast Cancer Group,Genito-Urinary Cancers Group,Lymphoma Group,News,Radiation Oncology Group,Uncategorized

Studies opened since 1 January 2010

12 Mar 2010

EORTC trial 22085-10083
TROG 07.01
A randomised phase III study of radiation doses and fractionation schedules for ductal carcinoma in situ (DCIS) of the breast

STUDIES IN REGULATORY PROCESS

EORTC trial 10085
Clinical and biological characterization of Male Breast Cancer: an international retrospective EORTC, BIG and NABCG intergroup study

EORTC trial 21081
A phase III study of lenalidomide maintenance after debulking with gemcitabine or liposomal doxorubicin +/- radiotherapy in patients with advanced cutaneous T-cell lymphoma not previously treated with intravenous chemotherapy

EORTC trial 30073
Randomized phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma.
SURTIME SURgery TIME

Cookie	Duration	Description
_GRECAPTCHA	5 months 27 days	This cookie is set by Google. In addition to certain standard Google cookies, reCAPTCHA sets a necessary cookie (_GRECAPTCHA) when executed for the purpose of providing its risk analysis.
cookielawinfo-checkbox-advertisement	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	1 year	This cookies is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visted in an anonymous form.

Cookie	Duration	Description
IDE	1 year 24 days	Used by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
test_cookie	15 minutes	This cookie is set by doubleclick.net. The purpose of the cookie is to determine if the user's browser supports cookies.
VISITOR_INFO1_LIVE	5 months 27 days	This cookie is set by Youtube. Used to track the information of the embedded YouTube videos on a website.
YSC	session	This cookies is set by Youtube and is used to track the views of embedded videos.

Cookie	Duration	Description
cookielawinfo-checkbox-functional	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
ep201	30 minutes	This cookie is set by the provider Surveymonkey. This cookie is used for statistical analysis and website optmization. It gathers information on user's interaction with the SurveyMonkey- Widget on thewebsite.
ep202	3 months	This cookie is set by the provider Surveymonkey. This cookie is used for statistical analysis and website optmization. It gathers information on user's interaction with the SurveyMonkey- Widget on thewebsite.

Studies opened since 1 January 2010

Related News

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research

IMMUcan has completed patient enrolment

EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients

Pink October at EORTC: Over 60 years of impactful breast cancer research

Spotlight on ENA 2024 News

Do regulations and policies undermine the social value of independent academic research?

EORTC Quality of Life Group’s participation to ISOQOL 2024

New Insights into Glioblastoma Treatment for Older Adults Patients

TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival

Share

Studies opened since 1 January 2010

Related News

EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma

Minister F. Vandenbroucke visits EORTC Headquarters to strengthen collaborative efforts in clinical cancer research

IMMUcan has completed patient enrolment

EORTC SPRINT clinical cancer study receives support from Rising Tide Foundation to reduce the burden for patients

Pink October at EORTC: Over 60 years of impactful breast cancer research

Spotlight on ENA 2024 News

Do regulations and policies undermine the social value of independent academic research?

EORTC Quality of Life Group’s participation to ISOQOL 2024

New Insights into Glioblastoma Treatment for Older Adults Patients

TOPGEAR trial results show no significant benefit of preoperative chemoradiotherapy on long term survival